Given that sEH deletion and 12,13-EpOME treatment increased the proliferation of matrix cells, sEH inhibition could serve as a therapeutic option for treatment of hair loss at early stages of cancer therapy by prolonging the anagen stage. The gene discussed is EPHX2; the disease is cancer.